Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PYXS | VRCA | CSBR | ||
| Company | Pyxis Oncology Inc | Verrica Pharmaceuticals Inc | Champions Oncolog | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5200 | 6.20 | 5.83 | ||
| High | 1.5386 | 6.39 | 5.95 | ||
| Low | 1.4050 | 5.67 | 5.82 | ||
| Latest | 1.4200 | 5.79 | 5.82 | ||
| Change | -0.1100 | -0.51 | -0.23 | ||
| % Change | -7.19% | -8.10% | -3.80% | ||
| Volume | 238,300 | 71,400 | 3,900 | ||
| 20-Day Average Volume | 524,330 | 137,515 | 6,790 | ||
| Previous Close | 1.5300 | 6.30 | 6.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4695 | 6.63 | 6.57 | ||
| 20-Day Raw Stochastic | 33.71% | 16.31% | 0.53% | ||
| 20-Day Relative Strength | 40.94 | 40.66 | 39.34 | ||
| Weighted Alpha | +46.41 | -68.52 | -33.75 | ||
| Today's Opinion | 80% Sell | 8% Sell | 72% Sell | ||
| Previous Opinion | 64% Sell | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 24% Sell | 64% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.19% since 02/12/26 | +4.14% since 02/12/26 | -2.18% since 02/12/26 | ||
| Low | 1.2700 on 02/17/26 | 5.38 on 02/18/26 | 5.81 on 02/18/26 | ||
| High | 1.5400 on 02/19/26 | 6.39 on 02/20/26 | 6.20 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | -14.46% since 01/20/26 | -27.08% since 01/20/26 | -16.86% since 01/20/26 | ||
| Low | 1.2700 on 02/17/26 | 5.38 on 02/18/26 | 5.81 on 02/18/26 | ||
| High | 1.7600 on 01/22/26 | 8.24 on 01/21/26 | 7.71 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | -68.65% since 11/20/25 | +44.03% since 11/20/25 | -12.61% since 11/20/25 | ||
| Low | 1.0300 on 12/26/25 | 3.90 on 11/21/25 | 5.81 on 02/18/26 | ||
| High | 5.5500 on 11/26/25 | 9.82 on 11/28/25 | 8.31 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +22.41% since 08/20/25 | +4.14% since 08/20/25 | -20.49% since 08/20/25 | ||
| Low | 1.0300 on 12/26/25 | 3.28 on 11/04/25 | 5.81 on 02/18/26 | ||
| High | 5.5500 on 11/26/25 | 9.82 on 11/28/25 | 8.74 on 09/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 88,415 | 92,582 | 80,816 | ||
| Shares Outstanding, K | 62,264 | 15,990 | 13,886 | ||
| Annual Sales | 16,150,000 | 7,570,000 | 56,940,000 | ||
| Annual Net Income | -77,330,000 | -76,580,000 | 4,700,000 | ||
| Last Quarter Sales | 2,820,000 | 14,340,000 | 15,040,000 | ||
| Last Quarter Net Income | -18,350,000 | -270,000 | 270,000 | ||
| 60-Month Beta | 1.45 | 1.46 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 11/03/25 | 0.13 on 11/14/25 | 0.02 on 12/15/25 | ||
| Latest Earnings Date | 03/17/26 | 03/10/26 | 03/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 35.59 | ||